Viatris VTRS
NASDAQ VTRS
$21.06 +0.21 (+1.01%)
As of: Nov 11, 2026 · 3:47 PM EST

Viatris (VTRS) Return on Capital Employed [ROCE] (2020 - 2026)

Updated

Viatris (VTRS) posted Return on Capital Employed [ROCE] of -0.29% for Q2 2026, up 8.02 percentage points from -8.31% a year earlier but down 0.76 percentage points from the prior quarter.

Analysis

Viatris (VTRS) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends

For FY2025, Viatris' Return on Capital Employed [ROCE] came in at -8.26%, down 8.28 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has declined for three consecutive years, with a five-year change of -7.67 percentage points (FY2020 to FY2025).
  • In prior years, Viatris' Return on Capital Employed [ROCE] was 0.03% in FY2024 (-1.84 pp), 1.87% in FY2023 (-1.67 pp), 3.53% in FY2022 (+3.61 pp) and -0.07% in FY2021 (+0.52 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -8.98% in Q1 2025 to a high of 4.01% in Q3 2022 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in two of the last eight quarters, with an average year-over-year change of -2.86 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q1 2026, with a gain of 9.44 percentage points; the weakest was Q1 2025, with a drop of 10.41 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was 0.46% (Q1 2026), -8.74% (Q4 2025) and -8.60% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Viatris 23.90 Bn 17.07 Bn 1.44 Bn -0.02%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -0.02%
Jun 30, 2026 -0.29%
Mar 31, 2026 0.46%
Dec 31, 2025 -8.74%
Sep 30, 2025 -8.60%
Jun 30, 2025 -8.31%
Mar 31, 2025 -8.98%
Dec 31, 2024 0.03%
Sep 30, 2024 -0.71%
Jun 30, 2024 -0.10%
Mar 31, 2024 1.43%
Dec 31, 2023 1.89%
Sep 30, 2023 2.43%
Jun 30, 2023 2.66%
Mar 31, 2023 3.00%
Dec 31, 2022 3.79%
Sep 30, 2022 4.01%
Jun 30, 2022 3.44%
Mar 31, 2022 2.11%
Dec 31, 2021 -0.07%
API Access

Viatris Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=VTRS&period=max&api_key=YOUR_API_KEY